Public health authorities in the United States are investigating what appears to be a second outbreak of fungal infections associated with compounded steroid injections. The compounding pharmacy being investigated has recalled all lots of products that are intended to be sterile.
The suspected outbreak has spurred a multistate investigation by authorities from the US Food and Drug Administration (FDA), the US Centers for Disease Control and Prevention (CDC), and local public health authorities from Illinois, North Carolina, Florida, and Tennessee. The investigation comes on the heels of an ongoing outbreak of fungal meningitis cases caused by contaminated steroid injections produced by a Massachusetts-based compounding pharmacy that began last fall and that caused illness in more than 740 patients, killing 55 of them.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.